bioAffinity Technologies (bioAffinity Technologies) Net Margin % : -81.55% (As of Mar. 2024)

View and export this data going back to 2022. Start your Free Trial

What is bioAffinity Technologies Net Margin %?

Net margin is calculated as Net Income divided by its Revenue. bioAffinity Technologies's Net Income for the three months ended in Mar. 2024 was $-1.96 Mil. bioAffinity Technologies's Revenue for the three months ended in Mar. 2024 was $2.41 Mil. Therefore, bioAffinity Technologies's net margin for the quarter that ended in Mar. 2024 was -81.55%.

The historical rank and industry rank for bioAffinity Technologies's Net Margin % or its related term are showing as below:

BIAFW' s Net Margin % Range Over the Past 10 Years
Min: -163080 Med: -81696.74 Max: -169.46
Current: -169.46

BIAFW's Net Margin % is ranked worse than
78.9% of 218 companies
in the Medical Diagnostics & Research industry
Industry Median: -12.535 vs BIAFW: -169.46

bioAffinity Technologies Net Margin % Historical Data

The historical data trend for bioAffinity Technologies's Net Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

bioAffinity Technologies Net Margin % Chart

bioAffinity Technologies Annual Data

Trend

Dec20

Dec21

Dec22

Dec23

Net Margin %

-163,080.00

-313.47

bioAffinity Technologies Quarterly Data
	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Net Margin %	Get a 7-Day Free Trial									-153,300.00	-8,700.00	-768.79	-107.23	-81.55

Competitive Comparison of bioAffinity Technologies's Net Margin %

For the Diagnostics & Research subindustry, bioAffinity Technologies's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

bioAffinity Technologies's Net Margin % Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, bioAffinity Technologies's Net Margin % distribution charts can be found below:

* The bar in red indicates where bioAffinity Technologies's Net Margin % falls into.

bioAffinity Technologies Net Margin % Calculation

Net margin - also known as net profit margin is the ratio of Net Income divided by net sales or Revenue, usually presented in percent.

bioAffinity Technologies's Net Margin for the fiscal year that ended in Dec. 2023 is calculated as

Net Margin	=	Net Income (A: Dec. 2023 )	/	Revenue (A: Dec. 2023 )
	=	-7.937	/	2.532
	=	-313.47 %

bioAffinity Technologies's Net Margin for the quarter that ended in Mar. 2024 is calculated as

Net Margin	=	Net Income (Q: Mar. 2024 )	/	Revenue (Q: Mar. 2024 )
	=	-1.962	/	2.406
	=	-81.55 %

bioAffinity Technologies (NAS:BIAFW) Net Margin % Explanation

Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.

But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.

bioAffinity Technologies Net Margin % Related Terms

Thank you for viewing the detailed overview of bioAffinity Technologies's Net Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

bioAffinity Technologies (bioAffinity Technologies) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » bioAffinity Technologies Inc (NAS:BIAFW) » Definitions » Net Margin %

Comparable Companies

Traded in Other Exchanges

BIAF:USA

Address

22211 W Interstate 10, Suite 1206, San Antonio, TX, USA, 78257

Website

https://www.bioaffinitytech.com

bioAffinity Technologies Inc addresses the need for noninvasive diagnosis of early-stage cancer and diseases of the lung and targeted cancer treatment. It develops proprietary noninvasive diagnostic tests and cancer therapeutics using technology that preferentially targets cancer cells and cell populations indicative of a diseased state. The company is involved in developing technologies that, in the future, will be able to detect and monitor diseases of the lung and other cancers and treat many cancers.